GGGavin P Guy

Gavin P Guy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gavin P Guy has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • AI to Assist in the Fetal Anomaly Ultrasound Scan: A Randomized Controlled Trial

    by Thomas G. Day, Jacqueline Matthew, Samuel F. Budd, Alfonso Farruggia, Lorenzo Venturini, Robert Wright, Babak Jamshidi, Meekai To, Huazen Ling, Jonathon Lai, et al.


  • Effect of routine first‐trimester combined screening for pre‐eclampsia on small‐for‐gestational‐age birth: secondary interrupted time series analysis

    by G. P. Guy, K. Leslie, D. Diaz Gomez, K. Forenc, E. Buck, A. Bhide, B. Thilaganathan

    Objective: To evaluate the impact of a first‐trimester combined screening program for pre‐eclampsia, based on the Fetal Medicine Foundation (FMF) algorithm, on the rate of small‐for‐gestational age (SGA) at birth and adverse pregnancy outcome.Methods: This was a retrospective cohort study of data obtained from a London tertiary hospital between January 2017 and March 2019. The data were derived from a secondary analysis of the cohort evaluated in a clinical‐effectiveness study on the implementation of a first‐trimester screening program for pre‐eclampsia. The cohort included 7720 women screened according to the UK National Institute for Health and Care Excellence (NICE) risk‐based approach and 4841 women screened by the FMF multimodal approach, which combines maternal risk factors, blood pressure, pregnancy‐associated plasma protein‐A and uterine artery Doppler indices. The care package for the FMF‐screened group included 150‐mg aspirin prophylaxis, ultrasound scans at 28 and 36 weeks' gestation and scheduled delivery at 40 weeks. Outcome measures included the rates of SGA neonates at birth, admission to the neonatal unit, intrauterine demise, neonatal death and hypoxic–ischemic encephalopathy assessed by interrupted time series analysis (ITSA).Results: There was no significant difference in the rates of intrauterine demise, neonatal death and hypoxic–ischemic encephalopathy between the FMF‐screened and NICE‐screened cohorts. ITSA showed a significant reduction in the rate of term SGA birth < 10th percentile at 21 months following implementation of the FMF screening program, with a relative effect reduction of 45.1% (P = 0.004). However, there was no significant relative effect reduction in term SGA birth < 5th or < 3rd percentile.Conclusions: First‐trimester combined screening for pre‐eclampsia based on the FMF algorithm accompanied by a care package including serial ultrasound scans for growth evaluation and elective birth from 40 weeks' gestation resulted in a significant 45% relative effect reduction in term SGA birth < 10th percentile but did not affect term SGA birth < 5th or < 3rd percentile. Further screening strategies to detect and improve the outcome of cases with SGA birth < 5th percentile need to be considered. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.


  • Open Access

    Secondary non‐invasive prenatal screening for fetal trisomy: an effectiveness study in a public health setting

    by Gavin P Guy, Joanne Hargrave, Rache Dunn, Kell Price, Joh Short, Basky Thilaganathan, the SAFE test collaborative

    Objective: To evaluate the effectiveness of secondary screening using non‐invasive prenatal testing (NIPT) in a routine NHS setting including test performance, turn‐around times (TATs) and no‐call (failure to obtain result) rates. To examine the influence of maternal and fetal characteristics on test performance.Design: Retrospective cohort.Setting: London teaching hospital.Sample: A total of 8651 pregnancies undergoing screening for fetal trisomy using NIPT provided by an NHS cell‐free DNA screening laboratory – the SAFE laboratory.Methods: Screening test evaluation and TATs. Univariate and multivariate logistic regression analysis to identify significant predictors of no‐call results and reported by low fetal fraction (40%) and processing failure.Main outcome measures: Test performance, TATs and no‐call rates, factors affecting no‐call results.Results: Average TAT was 4.0 days (95% CI 4.0–4.2 days). Test sensitivities for trisomies 21 and 13/18 were 98.9% (95% CI 95.9–99.9%) and 90.4% (95% CI 80.0–96.8%), respectively. The overall no‐call rate was 32/8651 (0.37%, 95% CI 0.26–0.52%). The overall risk of a no‐call result was influenced by gestational age, dichorionic twin pregnancy, history of malignancy and pregnancies affected by trisomy 13/18, but not by maternal weight or use of low‐molecular‐weight heparin.Conclusions: High‐throughput NIPT can be effectively embedded into a public health NHS setting. TATs of 4 days and no‐calls of <0.5% were well within clinically desirable tolerances. Gestational age, maternal weight, assisted reproductive techniques, use of low‐molecular‐weight heparin and past history of malignancy did not have major impacts on test no‐call rates and should not constitute reasons for withholding the option of NIPT from women.Tweetable Turn‐around times of 4 days, no‐call (test failure) rates of 0.37% and highly accurate NIPT can be successfully embedded in the NHS.


  • Maternal hemodynamics in screen‐positive and screen‐negative women of the ASPRE trial

    by Hua Zen Ling, G. P. Guy, Alesandra Bisquera, Liona C. Poon, Kypros Nicolaides, Nikos A. Kametas

    Objective: To compare maternal hemodynamics and perinatal outcome, in pregnancies that do not develop pre‐eclampsia (PE) or deliver a small‐for‐gestational‐age (SGA) neonate, between those identified at 11–13 weeks' gestation as being screen positive or negative for preterm PE, by a combination of maternal factors, mean arterial pressure, uterine artery pulsatility index, serum placental growth factor and pregnancy associated plasma protein‐A.Methods: This was a prospective longitudinal cohort study of maternal cardiovascular function, assessed using a bioreactance method, in women undergoing first‐trimester screening for PE. Maternal hemodynamics and perinatal outcome were compared between screen‐positive and screen‐negative women who did not have a medical comorbidity, did not develop PE or pregnancy‐induced hypertension and delivered at term a live neonate with birth weight between the 5th and 95th percentiles. A multilevel linear mixed‐effects model was used to compare the repeated measures of cardiac variables, controlling for maternal characteristics.Results: The screen‐negative group (n = 926) had normal cardiac function changes across gestation, whereas the screen‐positive group (n = 170) demonstrated static or reduced cardiac output and stroke volume and higher mean arterial pressure and peripheral vascular resistance with advancing gestation. In the screen‐positive group, compared with screen‐negative women, birth‐weight Z‐score was shifted toward lower values, with prevalence of delivery of a neonate below the 35th, 30th or 25th percentile being about 70% higher, and the rate of operative delivery for fetal distress in labor also being higher.Conclusion: Women who were screen positive for impaired placentation, even though they did not develop PE or deliver a SGA neonate, had pathological cardiac adaptation in pregnancy and increased risk of adverse perinatal outcome. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.


  • Effect of change in posture on maternal functional hemodynamics at 35–37 weeks' gestation

    by Gavin P Guy, H. Z. Ling, Mirian Machuca, Liona C Poon, Kypros H Nicolaides

    Objectives: To evaluate the effect of posture change from the supine to the sitting position and before and after passive leg raising on maternal functional hemodynamics in pregnant women at 35–37 weeks' gestation, and to compare the changes in pregnancies that subsequently developed pre‐eclampsia (PE) or gestational hypertension (GH) with those that remained normotensive.Methods: In 2764 singleton pregnancies at 35–37 weeks' gestation, maternal cardiovascular parameters were measured using an automated non‐invasive cardiac monitor. The hemodynamic response to a change from the supine to the sitting position and before and after passive leg raising in the left lateral position was examined and compared between women who subsequently developed PE or GH and those who remained normotensive.Results: In normotensive singleton pregnancies at 35–37 weeks' gestation, both change from the supine to the sitting position and passive leg raising were associated with an increase in cardiac index and stroke volume index and a decrease in total peripheral resistance index; there was a small increase in mean arterial pressure with both postural changes and a slight decrease in heart rate with passive leg raising. In pregnancies that subsequently developed PE or GH, compared with normotensive pregnancies, cardiac index and stroke volume index were lower and total peripheral resistance index was higher. In general, change from the supine to the sitting position and passive leg raising were associated with similar but less marked changes in cardiovascular parameters as in normotensive pregnancies.Conclusions: Paradoxically, in late third‐trimester normal pregnancy, both change from the supine to a sitting position and passive leg raising may result in an increase in preload with a consequent increase in cardiac and stroke volume indices and a decrease in total peripheral resistance index. In pregnancies that develop PE or GH, the effects of postural change on cardiovascular parameters are similar but less marked than in normotensive pregnancies. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.


  • Maternal cardiac function at 35–37 weeks' gestation: prediction of pre‐eclampsia and gestational hypertension

    by G. P. Guy, H. Z. Ling, P. Garcia, L. C. Poon, K. H. Nicolaides

    To investigate the potential value of combining maternal factors with multiples of the normal median values of maternal cardiovascular parameters at 35–37 weeks' gestation in the prediction of pre-eclampsia (PE) and gestational hypertension (GH). In 2764 singleton pregnancies maternal characteristics and medical history were recorded; uterine artery pulsatility index (UtA-PI), mean arterial pressure (MAP) and maternal cardiovascular parameters were measured. Multivariable logistic regression analysis was then used to determine if the maternal factors and maternal cardiovascular parameters made a significant contribution to predicting PE and GH. The performance of screening was determined by the area under receiver–operating characteristics curves. In pregnancies that subsequently delivered with PE or GH, total peripheral resistance and MAP were higher and maternal cardiac output was lower, mainly owing to a decrease in heart rate in PE and a decrease in stroke volume in GH. The increases in total peripheral resistance and MAP were inversely related to gestational age at delivery. The performance of screening for PE and GH achieved by maternal characteristics and medical history was improved by the inclusion of MAP, but not by UtA-PI or maternal cardiovascular parameters. In women developing term PE total peripheral resistance and MAP are increased and maternal cardiac output is reduced. However, assessment of maternal cardiac function at 35–37 weeks' gestation is unlikely to improve the performance of screening for PE provided by maternal factors and MAP alone. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.


  • Maternal cardiovascular function at 35–37 weeks' gestation: relation to maternal characteristics

    by G. P. Guy, H. Z. Ling, P. Garcia, L. C. Poon, K. H. Nicolaides

    To examine the possible effects of maternal characteristics and obstetric and medical history on maternal cardiovascular parameters at 35–37 weeks' gestation. In 3013 singleton pregnancies at 35–37 weeks, maternal characteristics and medical history were recorded; uterine artery pulsatility index, mean arterial pressure (MAP) and maternal cardiovascular parameters were measured. Multivariable regression analysis was used to determine significant predictors of the cardiovascular parameters among gestational age (GA), maternal characteristics and medical history. Multivariable regression analysis demonstrated that significant independent prediction of log10cardiac output and log10cardiac power was provided by GA, maternal age, weight, weight gain from the first trimester, height, racial origin, smoking, assisted conception and previous neonatal birth-weight Z-score in parous women. For log10total peripheral resistance, significant prediction was provided by GA, maternal age, height, racial origin, chronic hypertension, diabetes mellitus, assisted conception, previous neonatal birth-weight Z-score and prior pre-eclampsia (PE) in parous women. For log10stroke volume, significant prediction was provided by maternal age, height, racial origin, smoking, chronic hypertension and diabetes mellitus. For heart rate, significant prediction was provided by GA, weight, weight gain, height, racial origin, chronic hypertension, previous neonatal birth-weight Z-score and prior PE in parous women. For log10MAP, significant prediction was provided by maternal weight, racial origin, family history of PE, chronic hypertension and diabetes mellitus. For log10thoracic fluid capacity, significant prediction was provided by GA, maternal age, weight, height, racial origin and systemic lupus erythematosus or antiphospholipid syndrome. For log10ventricular ejection time, significant prediction was provided by GA, weight, height and racial origin. Maternal cardiovascular parameters are affected by maternal characteristics and medical and obstetric history, and they should therefore be converted into multiples of the normal median adjusted for significant independent predictors before their inclusion in combined screening for PE. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.


  • Maternal cardiac function at 35–37 weeks' gestation: relationship with birth weight

    by G. P. Guy, H. Z. Ling, M. Machuca, L. C. Poon, K. H. Nicolaides

    Objective: To evaluate the relationship between maternal cardiovascular parameters and neonatal birth weight and examine the potential value of these parameters in improving the prediction of small‐for‐gestational‐age (SGA) and large‐for‐gestational‐age (LGA) neonates provided by maternal characteristics and medical history.Methods: In 2835 singleton pregnancies maternal characteristics and medical history were recorded and maternal cardiovascular parameters were measured. The observed measurements of cardiovascular parameters were expressed as multiples of the normal median (MoM) values after adjustment for those characteristics found to provide a substantial contribution to their measurement. Regression analysis was used to determine the significance of association between the normalized values of the cardiovascular parameters with birth‐weight Z‐score. Multivariable logistic regression analysis was then used to determine if the maternal factors, fetal biometry and maternal cardiovascular parameters had a significant contribution to predicting SGA and LGA neonates. The performance of screening was determined by the area under receiver–operating characteristics curves (AUC).Results: In the study population there were significant positive associations between maternal cardiac output and heart rate with neonatal birth‐weight Z‐score, and significant negative associations between total peripheral resistance and mean arterial pressure (MAP) with neonatal birth‐weight Z‐score. In pregnancies delivering SGA neonates (n = 249 (8.8%)), cardiac output and heart rate were lower and total peripheral resistance and MAP were higher, whereas in pregnancies delivering LGA neonates (n = 292 (10.3%)) cardiac output and heart rate were higher and total peripheral resistance and MAP were lower. The performance of screening for delivery of SGA neonates achieved by maternal characteristics and fetal biometry was not improved by the measurement of maternal cardiovascular parameters. There was a small but significant improvement in the performance of screening for delivery of LGA neonates by maternal factors and fetal biometry with the addition of maternal heart rate (comparison of AUC, P = 0.0095).Conclusions: There are significant associations between maternal cardiac output, heart rate, total peripheral resistance and MAP and neonatal birth‐weight Z‐score; such findings reflect the close relationship between maternal cardiac function and fetal demands. However, assessment of these parameters at 35–37 weeks' gestation is unlikely to improve substantially the performance of screening for SGA or LGA neonates provided by a combination of maternal factors and fetal biometry. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.